Switch to
Predicate | Object |
---|---|
rdf:type | |
lifeskim:mentions | |
pubmed:issue |
1
|
pubmed:dateCreated |
1980-7-26
|
pubmed:language |
eng
|
pubmed:journal | |
pubmed:citationSubset |
AIM
|
pubmed:chemical | |
pubmed:status |
MEDLINE
|
pubmed:month |
Jul
|
pubmed:issn |
0028-4793
|
pubmed:author | |
pubmed:issnType |
Print
|
pubmed:day |
3
|
pubmed:volume |
303
|
pubmed:owner |
NLM
|
pubmed:authorsComplete |
Y
|
pubmed:pagination |
48-9
|
pubmed:dateRevised |
2006-11-15
|
pubmed:meshHeading |
pubmed-meshheading:7374739-Action Potentials,
pubmed-meshheading:7374739-Animals,
pubmed-meshheading:7374739-Anti-Arrhythmia Agents,
pubmed-meshheading:7374739-Death, Sudden,
pubmed-meshheading:7374739-Guinea Pigs,
pubmed-meshheading:7374739-Myocardial Infarction,
pubmed-meshheading:7374739-Papillary Muscles,
pubmed-meshheading:7374739-Sulfinpyrazone
|
pubmed:year |
1980
|
pubmed:articleTitle |
The anturane reinfarction trial.
|
pubmed:publicationType |
Letter,
In Vitro
|